Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Group Elite Raises Over $72,000 for SickKids Clinical Trial


Group Elite SickKids

Group Elite is proud to announce that their recent campaign raised over $72,000 for the SickKids Foundation, in support of a retinoblastoma clinical trial led by The Hospital for Sick Children (SickKids).

The team at Group Elite is proud to announce that their recent campaign raised over $64,000 for the SickKids Foundation, in support of a retinoblastoma clinical trial led by The Hospital for Sick Children (SickKids). As part of their 10-Year Anniversary celebration, Group Elite created a campaign called, “We Have the Power” to raise money to support retinoblastoma research. The campaign had an initial goal of $10,000 and generous donations from employees and global partners were made in Canada and the United States.

“The generosity of our extended Group Elite family astounds me,” shared Michael Moore. “Through personal gifts and donated vacation days, we are proud to support the remarkable team at SickKids with these contributions.”

For over 3 years, the Group Elite team continues an indirect relationship with a special girl from Montreal named Ella suffering from retinoblastoma. Retinoblastoma is a rare but devastating form of childhood cancer affecting the retina at the back of the eye, and Ella’s treatment requires the care of a multidisciplinary team of paediatric oncologists and ophthalmologists. Recently a new treatment option designed to kill the tumour cells and preserve vision was made possible through a clinical trial led by Dr. Brenda Gallie, Ophthalmologist in the Department of Ophthalmology and Vision Sciences at SickKids. The trial findings may provide a step toward new treatment options for patients with retinoblastoma.

SickKids, affiliated with the University of Toronto, is one of Canada’s most research-intensive hospitals and the largest centre dedicated to improving children’s health in the country. SickKids also plays a crucial role as an international referral centre for treating retinoblastoma patients.

Gifts to the SickKids Foundation can still be made on the “We Have the Power” website at https://www.grouplelite.com/sickkids.

Share article on social media or email:

American College of Lifestyle Medicine Names Award-Winning Harvard Medical School Faculty Member and Author Dr. Beth Frates 2022-24 President


Dr. Beth Frates is President of the American College of Lifestyle Medicine.

It is an honor and joy to serve as ACLM president and to work closely with the thousands of dedicated health professionals it represents in pursuit of a redesigned, value-based and equitable health care delivery system.

The American College of Lifestyle Medicine (ACLM) has announced the transition of Beth Frates, MD, FACLM, DipABLM, an assistant clinical professor at Harvard Medical School, award winning teacher and author, from president-elect to a two-year term as president of the medical professional association that represents more than 9,000 physicians and other health professionals.

Dr. Frates succeeds Cate Collings, MD, MS, FACC, DipABLM, who transitions into the role of immediate past president after a highly successful two-year term.

ACLM is the only medical professional organization that educates, equips, and supports certification of physicians and other clinicians in lifestyle medicine. The growing medical specialty uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes, and obesity. Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions. Applying the six pillars of lifestyle medicine—a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connections—also provides effective prevention for these conditions.

Dr. Frates has devoted much of her career to advancing lifestyle medicine as a specialized field with board certification and to help fill the gaping void of lifestyle medicine curricula taught in medical education. In 2008, she started the first Lifestyle Medicine Interest Group at Harvard Medical School and later developed and taught the first lifestyle medicine curriculum at the Harvard Extension School, where it remains one of the most well-received courses offered at the school.

As director of wellness programming at the Stroke Institute for Research and Recovery at Spaulding Rehabilitation Hospital, a Harvard Medical School affiliate, Dr. Frates created and implemented a 12-step wellness program, PAVING the Path to Wellness™ for patients and providers. That led to her co-authoring the book “PAVING the Path to Wellness Workbook: A Guide to Thriving with a Healthy Body, Peaceful Mind and Joyful Heart.” She also co-authored “The Lifestyle Medicine Handbook: An Introduction to the Power of Healthy Habits” as well as “The Teen Lifestyle Medicine Handbook.”

Dr. Frates wrote a lifestyle medicine syllabus, which can be downloaded through the ACLM website, to serve as a template for other instructors and professors. As of fall 2022, she serves as director of lifestyle medicine and wellness for the Department of Surgery at Mass General Hospital. Dr. Frates is also a lifestyle medicine consultant and wellness coach treating patients in individual and group settings.

Dr. Frates, the third woman to serve as ACLM president, assumes leadership at a time of growing recognition among health leaders and policymakers that the trajectory of chronic disease and health care spending in the U.S. is unsustainable, and that lifestyle medicine can deliver high-value care.

“Lifestyle medicine can address up to 80% of chronic diseases,” Dr. Frates said. “There is a mounting sense of urgency that our current health care strategies are failing and that, by making lifestyle medicine the foundation of health care, we can arrest the decades-long rise in the prevalence of chronic conditions and their ever-increasing costs. It is an honor and joy to serve as ACLM president and to work closely with the thousands of dedicated health professionals it represents in pursuit of a redesigned, value-based and equitable health care delivery system.”

ABOUT ACLM

The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management. http://www.lifestylemedicine.org

Share article on social media or email:

SYNERGY HomeCare, Delray Beach, FL awarded CHAP Accreditation


Community Health Accreditation Partner, Inc., (CHAP) announced today that SYNERGY HomeCare, Delray Beach, FL has been awarded CHAP Accreditation under the CHAP Home Care Standards of Excellence.

CHAP Accreditation demonstrates that SYNERGY HomeCare, Delray Beach, FL meets the industry’s highest nationally recognized standards. The rigorous evaluation by CHAP focuses on structure and function, quality of services and products, human and financial resources, and long-term viability. Simply stated, adherence to CHAP’s standards leads to better quality care.

“By achieving CHAP Accreditation, SYNERGY HomeCare, Delray Beach, FL has shown a commitment to excellence,” said Nathan DeGodt, CHAP President & CEO. “This is the 13th year SYNERGY HomeCare, Delray Beach, FL has achieved CHAP Accreditation, and we are excited to continue our partnership by offering support in its commitment to providing quality care and continuous improvement.”

SYNERGY HomeCare, Delray Beach, FL provides a variety of homecare services such as personal care (bathing, dressing, toileting, feeding, ambulating, incontinence care), homemaking (laundry, make beds, change linens, light housekeeping tasks), companionship (errands such as doctor visits, grocery shopping, medication reminders), Live-in and respite services. SYNERGY HomeCare, Delray Beach provides services to anyone over 18 years living in southern and central Palm Beach County including cities of Delray Beach, Boca Raton, Highland Beach, Boynton Beach, Lake Worth, Lantana, West Palm Beach, Royal Palm Beach, and Wellington.

CHAP is an independent, not-for-profit, accrediting body for community-based health care organizations. Created in 1965, CHAP was the first to recognize the need and value for accreditation in community-based care. CHAP is the oldest national, community-based accrediting body with more than 9,000 agencies currently accredited nationwide. Through “deeming authority” granted by the Centers for Medicare and Medicaid Services (CMS), CHAP has the regulatory authority to survey agencies providing home health, hospice, and home medical equipment services, to determine if they meet the Medicare Conditions of Participation and CMS Quality Standards. CHAP’s purpose is to define and advance the highest standards of community-based care.

For more information about the CHAP accreditation process, please visit the CHAP website at https://www.chapinc.org. For additional information on CHAP, please contact Teresa Harbour, Senior Vice President, Accreditation, at 202.467.1701, or teresa.harbour@chapinc.org.

For additional information about SYNERGY HomeCare, Delray Beach, visit https://www.synergyhomecare.com/palmbeach or contact Vish Rajan, President/CEO at 561-276-9985

Share article on social media or email:

CABRI Awards $40,000 in Fellowships to Ten Undergraduate Researchers


CABRI Fellowship Recipients

2022 CABRI Fellowship Recipients

“These fellowships provide a valuable opportunity to undergraduates by allowing them to focus on gaining laboratory experience that builds their scientific talent,” said Kourtney Goode, Ph.D., Academic Relations Coordinator at Cayman.

Cayman joins the Cayman Biomedical Research Institute (CABRI) in recognizing the ten undergraduate students who have been awarded fellowships by CABRI for the 2022-2023 academic year. The fellowship awards are given to talented undergraduates that are pursuing a research project of their own under the guidance of a faculty mentor.

Undergraduate fellowships are awarded by CABRI on a competitive basis each year to students who have been offered an unpaid research position. “These fellowships provide a valuable opportunity to undergraduates by allowing them to focus on gaining laboratory experience that builds their scientific talent,” said Kourtney Goode, Ph.D., Academic Relations Coordinator at Cayman.

CABRI funds expanded opportunities for emerging scientists and awards research grants to academic scientists that address basic science research objectives with the highest unmet needs. More information about CABRI’s undergraduate fellowships, scholarships, and research funding opportunities is available on the CABRI website – https://www.cabrimed.org/research/grants-and-scholarships/.

The 2022 Recipients Are:

Addison Thompson

Washington State University

Mentor: Ryan McLaughlin

Project: Using Rodent Models to Interrogate Effects of Cannabis Use During Pregnancy on the Postpartum Phenotype

Branwen Jorenby

Augsburg University

Mentor: Matthew Beckman

Project: Developing a CRISPR Design to Disrupt Hedgehog in Drosophila melanogaster

Caitlyn Bartsch

Southern Illinois University, Carbondale

Mentor: Jacob Nordman

Project: Synaptogenesis and Early Life Stress-Induced Aggression (ELSIA)

Christopher Polera

University of Central Florida

Mentor: Otto Phanstiel

Project: Reprogramming Pancreatic Tumors via FUBP1 Inhibition

Jeremy Nelson

University of Michigan

Mentor: Kenneth Kwan

Project: Cortical Alterations Following Deletion of Wiedemann-Steiner Syndrome Gene Kmt2a

Laura Clark

Virginia Commonwealth University

Mentor: Santiago Lima

Project: Role of Glycosphingolipids in Cell Migration and Invasion in Cancer

McKenna Spencer

Washington State University

Mentor: Ryan McLaughlin

Project: Cannabis Use in Females: Influence of Ovarian Hormones on Cannabis Vapor Self-Administration in Female Rats

Roman Voskoboynikov

Pennsylvania State University, Berks Campus

Mentor: Justin DiAngelo

Project: The Regulation of Lipid Transport and Metabolism by the Splicing Factor Glorund in the Drosophila Intestine

Stevie Rieger

Case Western Reserve University

Mentor: John Letterio

Project: Targeting Cathepsin B to Overcome Radiation Resistance in DIPG

Victoria Glass

University of South Carolina School of Medicine

Mentor: Claudia Grillo

Project: Identification of Hypothalamic Neurons Involved in a Novel Circuit that Regulates Feeding Behavior

About Cayman Chemical

Cayman Chemical Company (https://www.caymanchem.com/) helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, Cayman Contract Services provides discovery and preclinical development services to the global pharmaceutical, biotechnology, and academic research markets. Our diverse suite of services leverages a team of over 150 highly skilled scientists with expertise in medicinal chemistry, structure-based drug design, complex multi-step organic synthesis, analytical chemistry, sample analysis, and custom assay development. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic.

About CABRI

Cayman Biomedical Research Institute (CABRI – https://www.cabrimed.org/) is a nonprofit organization which supports research on the rare illnesses and orphan diseases that are often neglected by the corporate pharmaceutical industry and actively pursues new developments that will treat these diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or preclinical development for these diseases as well as undergraduate grants to assist students to obtain experience in laboratories while performing research that aligns with CABRI’s mission. CABRI also provides scholarships to college-bound students who have lost a parent to SNUC (sinonasal undifferentiated carcinoma) or B cell lymphoma.

Share article on social media or email:

Validation Institute Releases an Employer’s Buyer’s Guide for Pharmacy Benefits


Validation Institute announced its newest buyer’s guide, an “Employer’s Guide to Drug Spend Management: Must-Know Strategies to Lower Prescription Drug Costs.” The buyer’s guide outlines key considerations and important questions employers must ask their brokers, PBMs, and vendors about smart, optimal drug spend management. It also discusses how employers are uniquely positioned to address the drug spend crisis by adopting innovative models that put the patient first and can result in significant cost savings and improved health outcomes.

According to a 2020 KFF report, the average employer cost for prescription drugs is $1,200 per person annually. Additionally, while only about 2% of the population uses specialty drugs, they contribute to 51% of the total pharmacy spend*.

“The KFF report is one example of how drug prices have spiraled for employers and there are many other examples from which to draw. Moreover, the trend is expected to continue. This guide steps through the levers that employers can pull to rein them in, including the impact of the Consolidated Appropriations Act (CAA), questions to ask your broker, how to create a better RFP, and the potential benefits of working with a pass-through, transparent PBM, “said Benny DiCecca, CEO of Validation Institute.

The Employer’s Guide to Drug Spend Management also features a new crop of PBMs whose contracts and outcomes have been reviewed by Validation Institute, including CapitalRx, DisclosedRx, Drexi, EmpiRx, Health Partners, and US-RX Care. A complimentary copy can be downloaded at: http://www.validationinstitute.com/buyers-guide/drug-spend-guide

Validation Institute also published a buyer’s guide on Musculoskeletal (MSK) Solution Providers earlier this year and is planning additional guides in 2023 on Chronic Disease Management, Fertility and Maternity Care, Primary and Virtual Care, and Behavioral Health. Organizations that want to download the MSK Guide and learn more about the 2023 schedule can visit http://www.validationinstitute.com/buyers-guides for additional details.

About Validation Institute

Validation Institute is a membership organization dedicated to providing unbiased, data-driven insights on health care solutions and services by validating performance claims made by solution providers and educating purchasers to drive transparency in the marketplace. By validating performance claims, Validation Institute guides purchasers in choosing the right solution providers that meet the needs of their population while improving outcomes, strengthening accountability, and saving costs.

*Evernorth Book of Business 2021.

Press Contact:

Sean Edwards

Chief Marketing Officer

Validation Institute

+1-781-939-2618

Sean.Edwards@validationinstitute.com

Share article on social media or email:

EARPEACE Named USA Today 10BEST for Travelers for their Readers Choice Awards


EARPEACE revolutionized hearing protection in 2008 with a discreet, comfortable, high-fidelity earplug.

In these post-pandemic times, our mission to keep people doing the things they love for a lifetime is more timely than ever. We are grateful for the extensive coverage that EARPEACE received this year and can’t wait to see what unfolds in 2023. -Jay Clark, CEO of EARPEACE.

Today, EARPEACE is announcing that they have been named USA Today’s 10BEST for their 2022 Readers’ Choice award for the Best Gift for Business Travelers category. EARPEACE SLEEP earplugs, which were re-engineered and re-launched in 2022, have been reviewed and selected by a panel of experts for their standout capabilities in sound reduction and ability to reduce unwanted noise up to 30db.

In addition to this prestigious recognition, EARPEACE was also prominently featured with top media publications in 2022 including The New York Times – Wirecutter, WIRED, Auto Week, Men’s Health, Men’s Journal “Coolest Gear of the Week,” Buzzfeed, Washington Business Journal, SiriusXM Radio, and many others. In addition to EAPREACE SLEEP, EARPEACE MUSIC and EARPEACE MOTO were widely praised by reporters and editors at some of the most sought-after media outlets.

“In these post-pandemic times, our mission to keep people doing the things they love for a lifetime is more timely than ever. With festivals, night clubs, and tours all back in action, it is so gratifying to provide a product that is such an important part of getting back out in the world of live events safely and comfortably,” said Jay Clark, CEO of EARPEACE. “We are grateful for the extensive coverage that EARPEACE received this year and can’t wait to see what unfolds in 2023.”

Coinciding with their widespread national media coverage in 2022, EARPEACE also announced new collaborations with NPR Music and The House Institute for custom lines of branded earplugs in order to reduce noise-induced hearing loss (NIHL) amongst core audiences and consumers nationwide.

According to the Centers for Disease Control and Prevention (CDC), in less than five minutes at a rock concert, NIHL has already begun. In the past year, roughly 25 million Americans have experienced tinnitus. As a result, hearing loss remains the third most common chronic physical condition in the United States and is twice as prevalent as diabetes or cancer.*

Recently granted their second patent for the proprietary design of their earplugs following their utility patent, EARPEACE PRO resolves a common problem in traditional earplugs that contain rigid components by eliminating the mismatch between the shape of the ear and plug. The earplugs use less material to optimally expand in the ear canal, minimizing unwanted bunching and slit leaks. In addition to the higher level of comfort, the oval, offset wave shape of their patented design permits the filters to perform at peak capacity.

Since 2008, EARPEACE has innovated hearing protection options and continues to lead the charge in maximizing the quality of people’s experiences, as well as efforts to reduce the epidemic of hearing loss and tinnitus. EARPEACE is trusted by NPR, Metallica, RedBull, Phish, Lollapalooza, and more.

For more information about EARPEACE, please visit: https://www.earpeace.com.

###

About EARPEACE:

EARPEACE revolutionized hearing protection in 2008 with a discreet, comfortable, high-fidelity earplug built not only for musicians, but for all the fans at the event. This same technology was customized for motorsports, and everyone that needs a good night’s sleep. The innovation by EARPEACE continues today with new patents, products, technologies, and accessories designed to enhance your experience. Festivals, motorcycle rallies, and events all over the world depend on EARPEACE to keep their stars and fans safe, comfortable, and ready for the next event. The EARPEACE promise is simple – you will hear and feel better when you wear EARPEACE. For more information, visit: https://www.earpeace.com.

*Based on calculations performed by NIDCD Epidemiology and Statistics Program staff: (1) tinnitus prevalence was obtained from the 2008 National Health Interview Survey (NHIS); (2) the estimated number of American adults reporting tinnitus was calculated by multiplying the prevalence of tinnitus by the 2013 U.S. Census population estimate for the number of adults (18+ years of age)(Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for US adults: National Health Interview Survey, 2012. Vital Health Stat 10. 2014;260:1-161.)

Share article on social media or email:

SweetNight Launches the Perfect Gift for the Holidays – The Eye Tech Mask


Sweet Night Technology Co., Ltd., the company behind the direct-to-consumer sleep brand ‘SweetNight’ has been slowly but surely conquering the U.S. during the last decade with their affordable prices and excellent value-for-money mattresses. Today they are now proud to announce a new product to their new sleep solutions product range: the Eye Tech Mask.

With the Eye Tech Mask, SweetNight gets past sleep boundaries to ensure daytime rest and relaxation not just at home but on the go as well. Powered by a 600mAh battery, with a smart, compact, and foldable design and hypoallergenic, skin-friendly fabric, the mask can be carried and used anywhere, anytime, from home to office, on plane trips, vacations, and more.

Its built-in massage and warm compress features are the perfect solution to soothe tired eyes, relieve stress and screen fatigue, and induce a state of calmness, relaxation, and well-being. And when those are not enough, you have the external ice pocket that can be fitted onto the mask to enjoy a cold compress. Preventing red, swollen eyes and dark circles is as easy as pressing a button!

According to the preliminary feedback, the device also helps relieve insomnia and improve sleep. A few minutes of use before bedtime are a great way to relieve the stress of the day, chase away negative thoughts, and prepare users for bed, helping them fall asleep faster and enjoy deeper, longer sleep. All these beneficial effects make the Eye Tech Mask an amazing gift for the holidays, especially with its unisex design and the average screen time exceeding 7 hours/day for Americans. Who wouldn’t appreciate a few moments of rest and relaxation, especially when delivered stylishly and so conveniently!

“While we still strive to offer the best value for the money, it’s time we showed everyone what our R&D and production teams can do. The Eye Tech Mask is the first step of our gradual expansion from sleep and bedroom products to wellness and lifestyle solutions that we’re sure everyone will appreciate. The next step is a revolutionary mobile wearable blanket launching in December and bound to keep users warm and cozy anytime and anywhere”, said SweetNight Brand Founder, Tony Huang.

SweetNight is a top-rated sleep and wellness brand that uses eco-friendly, certified-quality materials with innovative designs to deliver rest, relaxation, and an improved quality of life at an affordable price.

Share article on social media or email:

Rimidi Named to 2022 CB Insights’ Digital Health 150 List


News Image

The recognition is truly a testament to the work our team is doing to improve care coordination and collaboration for our customers and within the industry at large.

Driven in part by the company’s recent and rapid growth and expansion, Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, announced today it has been named to CB Insights’ Digital Health 150 list.

Utilizing the CB Insights platform, the research team selected the top 150 winners from a pool of over 13,000 private companies, including applicants and nominees. Companies were chosen based on factors including R&D activity, proprietary Mosaic scores, market potential, business relationships, investor profile, news sentiment analysis, competitive landscape, team strength, and tech novelty. The research team also reviewed over 3,000 Analyst Briefings submitted by applicants.

“From reimagining clinical care, to leveraging tech like AR/VR to improve surgical training, this year’s Digital Health 150 winners are transforming the future of healthcare with digital technology,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year’s winners.”

Digital health adoption continues to accelerate, with the digital health market size is expected to hit $1.5 trillion by 2030. As new devices and digital therapeutics come to market, clinicians will need a way to synthesize the growing amounts of data in a meaningful way that impacts patient care. Rimidi’s clinical management platform is meeting this need by bringing data from the latest innovations into the clinical workflow and supporting clinicians with guideline and patient-specific clinical decision support.

In addition to being recognized on the Digital Health 150 List, Rimidi was also recently named to AVIA Connect’s Top 50 Companies in Remote Patient Monitoring Report. Furthermore, the company’s entry to the 2022 American Medical Informatics Association(AMIA)/HL7 FHIR Applications competition, “Managing Postpartum Hypertension with Rimidi’s FHIR-enabled Cardiometabolic Management Platform” came in second place in this year’s competition.

“I could not be more proud of the entire Rimidi team for our great accomplishment of making this year’s CB Insights’ Digital Health 150 List. The recognition is truly a testament to the work our team is doing to improve care coordination and collaboration for our customers and within the industry at large,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “Now in our tenth year of business, we’re more committed than ever to furthering our mission of helping clinicians optimize data for better care, and we’re ready to hit the ground running in 2023 and beyond.”

For more information on Rimidi, its solutions, and to stay abreast of upcoming news and updates, visit http://www.rimidi.com.

About Rimidi

Created by doctors, Rimidi’s leading clinical management platform empowers healthcare organizations to optimize clinical workflows, enhance patient experiences and achieve quality objectives. By bringing together clinical decision support, remote patient monitoring and patient-reported outcomes in a unified, composable, FHIR-based platform, Rimidi supports a broad range of clinical use cases and institutional priorities across large and small healthcare organizations. For more information, visit rimidi.com and follow us on Twitter and LinkedIn.

Share article on social media or email:



SafetyStratus Launches EHS Spark for Production Release Notes


“We are always looking for ways to enhance our services by listening to our community and making not just the necessary adjustments, but the ones that best serve others.” -Greg Kwolek

SafetyStratus, the user-friendly enterprise EH&S software company, announced today the release of EHS Spark, a dedicated webpage for software production release notes. Building on the storehouse of SafetyStratus’ knowledge network, this addition extends the functional, collaborative content with enhanced documentation around changes, updates, and improvements. The release notes define important work done as a result of changing regulatory requirements and feedback from the current community members as they utilize SafetyStratus software to handle everyday work challenges.

This technical documentation has been separated into categories of “Changes” and “Updates,” spelled out in everyday language, and organized into separate color pallets for easy intake. Whenever SafetyStratus launches a new module or a product update, these enhancements will be succinctly detailed on EHS Spark. The team at SafetyStratus hopes that presenting this information to the public will be a valuable opportunity for partner and safety professional communications. With more prevalent safety conversations, we can accelerate the discovery and adoption of technologies that help mitigate workplace risks and adapt to changing regulations.

Greg Kwolek, Director of Product Management at SafetyStratus, says “Our ultimate goal is to optimize the processes around safety. Optimization necessitates constant feedback and improvement.” On the EHS Spark webpage, the production release notes’ description conveys that idea: “feedback transformed into product improvements.” Referring to the work done as part of a holistic effort to adapt SafetyStratus modules to specific company requirements or requests, Kwolek also stated, “We are always looking for ways to enhance our services by listening to our community and making not just the necessary adjustments, but the ones that best serve others.” To contribute input to the conversation of how we can all collaborate for a safer future, we invite the user community to “join the conversation” on the SafetyStratus webpage, or subscribe to receive notifications for updates to the different resources within the Knowledge Network.

To view the EHS Spark webpage, click here.

About SafetyStratus

==================

SafetyStratus is designed by EH&S professionals for EH&S professionals. Our multi-level technology platform brings user-friendly, practical innovation to Environmental, Health, and Safety management in Academia, Healthcare, Construction, and Manufacturing. Our aim is to always be learning. We save lives and the environment by successfully integrating knowledgeable people, sustainable processes, and transformative technology.

SafetyStratus has headquarters located in Plano, TX with an employee base of industry experts and leaders, spanning the globe.

For more information visit http://www.safetystratus.com or LinkedIn, Twitter, and Facebook.

Share article on social media or email:



MD Logic Health and Melanie Avalon Launch Berberine 500 to Expand AvalonX Line


“I’m so grateful that, with MD Logic Health, we were able to create a pure, potent, and powerful berberine supplement that meets the uncompromising standards my community expects and deserves.” – Melanie Avalon

MD Logic Health (“MD Logic”), a leading provider of USA-made professional-grade nutraceuticals and physician-recommended dietary supplements announced the latest AvalonX powered by MD Logic Health dietary supplement: Berberine 500. AvalonX, founded by Melanie Avalon, was built on a mission of purity, potency, transparency, and trust, and is quickly becoming the standard for Avalon’s fans, and others in the health-focused community.

With the launch of Berberine 500, AvalonX and MD Logic continue to create products unmatched in quality and purity. To formulate AvalonX supplements, MD Logic innovated a small batch production process, to support Avalon’s vision to create clean, environmentally friendly, pure supplements. AvalonX products contain ethically sourced, laboratory-tested raw ingredients. The raw ingredients remain isolated from the production facility until they have passed the compliance multistage lab analysis for identity, purity, strength, composition, and contaminants. The final product is tested again for these same core quality controls.

Berberine 500 is vegan and features a single active ingredient from the Berberis Aristata root. It contains no rice fillers, stearates, palmitates, dyes, hidden proprietary ingredients, or GMOs. While Berberine 500’s source certification indicated pesticide-free, Melanie Avalon insisted on conducting additional third-party tests for pesticides.

“Rising blood sugar levels are a key factor in metabolic syndrome and the obesity epidemic, and the standard American diet contains a significant amount of processed carbohydrates, which often spike blood sugar levels. I wanted to make a product that would help my audience in their pursuit of healthy glycemic control. We knew berberine, which has been used in Ayurveda medicine for thousands of years, had to be the next product launch, after our overwhelming success with our Serrapeptase 125 and Magnesium 8,” says Avalon.

“I’m so grateful that, with MD Logic Health, we were able to create a pure, potent, and powerful berberine supplement that meets the uncompromising standards my community expects and deserves.”

MD Logic Health COO and Cofounder Scott Emmens commented, “Berberine 500 is the masterpiece of collaboration with our partner Melanie Avalon. It is a uniquely produced berberine which I am very proud to have been a part of developing, and look forward to using it daily! Our partnership continues to deliver new innovations and quality dietary supplements to Melanie’s amazing fans and our MD Logic community. Our team works tirelessly to serve the AvalonX and MD Logic Health communities to produce pure, clean, sustainable supplements. I am so thankful for the tremendous support from our healthcare community and customers.”

About Melanie Avalon

Melanie Avalon is the host of The Intermittent Fasting Podcast with TEDx speaker and nurse practitioner Cynthia Thurlow, and The Melanie Avalon Biohacking Podcast, on which she interviews the world’s top doctors, authors, and researchers. Avalon’s shows have been featured in USA Today, LA Weekly, Entrepreneur, and many other news outlets, and net 700k+ monthly downloads. Avalon is also the author of What When Wine: Lose Weight and Feel Great with Paleo-Style Meals, Intermittent Fasting, and Wine, and creator of the top Apple app “Food Sense Guide.” Her thriving Facebook communities include 13K+ members. To learn more, visit https://melanieavalon.com.

Follow Melanie Avalon

Instagram: @melanieavalon

Twitter: @melanieavalon

LinkedIn: linkedin.com/in/melanieavalon

Facebook: http://facebook.com/missmelanieavalon

Facebook Groups:

IF Biohackers: Intermittent Fasting + Real Foods + Life

Lumen, Biosense & CGMs: Carbs, Fat, Ketones & Blood Sugar

Clean Beauty And Safe Skincare With Melanie Avalon

About MD Logic Health – Supplementing Life since 2005

MD Logic Health was founded in 2005 by Dr. Steinfeld, who recognized the importance of providing access to professional-grade, pure, high-quality nutrients as part of his patients’ overall health care. MD Logic remains dedicated to providing integrated healthcare professionals and patients with the highest-grade nutraceuticals. MD Logic Health products are manufactured under USA Good Manufacturing Standards, using sustainable resources and rigorously tested ingredients. MD Logic Health supports access to nutraceuticals, education, and awareness for today’s integrated healthcare provider and patient. MD Logic Health has been featured on CBS, ABC, NBC, and CW. To learn more, please visit https://www.mdlogichealth.com.

Follow MD Logic Health

Instagram: @mdlogichealth

Twitter: @mdlogichealth

LinkedIn: linkedin.com/company/md-logic

Facebook: facebook.com/mdlogichealth

TikTok: @mdlogichealth

MD LOGIC HEALTH CONTACT:

Jyoti Hardat

jhardat@mdlogichealth.com

Phone (877) 629-8711 x700

AVALONX CONTACT:

Melanie Avalon

contact@avalonx.us

Share article on social media or email: